- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
Danae Hamouda가 후원하는 임상 시험
총 1313 건
-
Jennifer R. Brown, MD, PhDAstraZeneca; TG Therapeutics, Inc.모집하지 않고 적극적으로
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; Pharmacyclics LLC.완전한
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Prometheus Laboratories; Miltenyi Biomedicine GmbH모집하지 않고 적극적으로만성 이식편 대 숙주병 | 만성 GVHD | 장기 이식 줄기 세포의 합병증미국
-
Patrick Ott, MD, PhDBristol-Myers Squibb; Oncovir, Inc.모집하지 않고 적극적으로
-
Lumicell, Inc.National Cancer Institute (NCI); Massachusetts General Hospital; Dana-Farber Cancer Institute완전한
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)완전한
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital완전한
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's Hospital완전한
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)완전한
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's Hospital완전한
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Amgen완전한
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Brigham and Women's Hospital완전한
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Pfizer; Beth Israel Deaconess Medical Center완전한
-
Massachusetts General HospitalPfizer; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center완전한
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Dana-Farber Cancer Institute완전한
-
Massachusetts General HospitalNovartis; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center완전한
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital종료됨
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Brigham and Women's Hospital완전한
-
James Cleary, MD, PhDLustgarten Foundation; Arcus Biosciences, Inc.모병
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI); Dana-Farber Cancer Institute모병
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Massachusetts Institute of Technology모병
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South Korea모집하지 않고 적극적으로
-
Boston Children's HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; Schering-Plough완전한
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Columbia University; Schering-Plough완전한
-
Massachusetts General HospitalGlaxoSmithKline; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center완전한
-
Mark Pomerantz, MDMerck Sharp & Dohme LLC; Rainier Therapeutics종료됨
-
Suzanne George, MDNovartis; Pfizer; Brigham and Women's Hospital완전한
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; AstraZeneca완전한
-
Stanford UniversityThe Dana Foundation; California Breast Cancer Research Program; The Wellness Community완전한
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Brigham and Women's Hospital완전한
-
Filipa Lynce, MDMerck Sharp & Dohme LLC; Zentalis Pharmaceuticals모병유방암 | 삼중 음성 유방암 | 유방암 여성 | HER2 음성 유방암 | 호르몬 수용체 음성 악성 종양 유방 삼중미국
-
Dana-Farber Cancer InstituteAdenoid Cystic Carcinoma Research Foundation; Gateway for Cancer Research모병
-
Dana-Farber Cancer InstituteJohns Hopkins University; GlaxoSmithKline; Translational Breast Cancer Research Consortium모병유방암 | 1기 유방암 | 2기 유방암 | HER2 음성 유방암 | 3기 유방암 | 유해한 PALB2 유전자 돌연변이 | 생식계열 BRCA1 유전자 돌연변이 | 생식계열 BRCA2 유전자 돌연변이미국
-
Beth Israel Deaconess Medical CenterJohns Hopkins University; Dana-Farber Cancer Institute; AstraZeneca모집하지 않고 적극적으로전이성 유방암 | 침윤성 유방암 | BRIP1 유전자 돌연변이 | PALB2 유전자 돌연변이 | ATM 유전자 돌연변이 | CHEK2 유전자 돌연변이 | NBN 유전자 돌연변이 | RAD51 유전자 돌연변이 | 체세포 돌연변이 유방암(BRCA1) | 체세포 돌연변이 유방암(BRCA2)미국
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's Hospital모집하지 않고 적극적으로
-
Geoffrey Shapiro, MD, PhDEli Lilly and Company; AstraZeneca완전한
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South Korea완전한1기 유방암 | 2기 유방암 | 초기 유방암 | 3기 유방암 | 화학 요법 유발 말초 신경병증(CIPN) | 탁산 유발 말초신경병증미국
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Beth Israel Deaconess Medical Center완전한
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Brigham and Women's Hospital완전한급성 골수성 백혈병 | 만성골수단구성백혈병 | 골수이형성 증후군-과도한 모세포를 동반한 불응성 빈혈미국
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's Hospital완전한
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's Hospital완전한
-
Massachusetts General HospitalNovartis; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center완전한
-
Dana-Farber Cancer InstituteNational Institute of Nursing Research (NINR); University of Washington완전한
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Boston Children's Hospital; Celgene Corporation완전한
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center완전한
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; University of Virginia; Schering-Plough완전한
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital완전한
-
American University of Beirut Medical CenterMakassed General Hospital; Rafic Hariri University Hospital; Hotel Dieu de France Hospital; Nabatieh Governmental Hospital 그리고 다른 협력자들완전한
-
Instituto Dante Pazzanese de CardiologiaFundação de Amparo à Pesquisa do Estado de São Paulo모병
-
Instituto Dante Pazzanese de CardiologiaFundação de Amparo à Pesquisa do Estado de São Paulo완전한